Literature DB >> 19291527

Prognostic models: a methodological framework and review of models for breast cancer.

Douglas G Altman1.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19291527     DOI： 10.1080/07357900802572110

Source DB:  PubMed          Journal:  Cancer Invest        ISSN： 0735-7907            Impact factor:   2.176


× No keyword cloud information.
  39 in total

1.  Evaluation of epirubicin-induced cardiotoxicity by two-dimensional strain echocardiography in breast cancer patients.

Authors:  Xiaojun Bi; Youbin Deng; Fanjing Zeng; Ying Zhu; Yuhan Wu; Ceyao Zhao; Chunlei Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-06-10

Review 2.  Reporting methods in studies developing prognostic models in cancer: a review.

Authors:  Susan Mallett; Patrick Royston; Susan Dutton; Rachel Waters; Douglas G Altman
Journal:  BMC Med       Date:  2010-03-30       Impact factor: 8.775

Review 3.  Reporting performance of prognostic models in cancer: a review.

Authors:  Susan Mallett; Patrick Royston; Rachel Waters; Susan Dutton; Douglas G Altman
Journal:  BMC Med       Date:  2010-03-30       Impact factor: 8.775

4.  How to derive and validate clinical prediction models for use in intensive care medicine.

Authors:  José Labarère; Bertrand Renaud; Renaud Bertrand; Michael J Fine
Journal:  Intensive Care Med       Date:  2014-02-26       Impact factor: 17.440

5.  Conditional long-term survival following minimally invasive robotic mitral valve repair: a health services perspective.

Authors:  Jimmy T Efird; William F Griffin; Preeti Gudimella; Wesley T O'Neal; Stephen W Davies; Patricia B Crane; Ethan J Anderson; Linda C Kindell; Hope Landrine; Jason B O'Neal; Hazaim Alwair; Alan P Kypson; Wiley L Nifong; W Randolph Chitwood
Journal:  Ann Cardiothorac Surg       Date:  2015-09

6.  BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received.

Authors:  S-J Dawson; N Makretsov; F M Blows; K E Driver; E Provenzano; J Le Quesne; L Baglietto; G Severi; G G Giles; C A McLean; G Callagy; A R Green; I Ellis; K Gelmon; G Turashvili; S Leung; S Aparicio; D Huntsman; C Caldas; P Pharoah
Journal:  Br J Cancer       Date:  2010-07-27       Impact factor: 7.640

7.  A flexible alternative to the Cox proportional hazards model for assessing the prognostic accuracy of hospice patient survival.

Authors:  Branko Miladinovic; Ambuj Kumar; Rahul Mhaskar; Sehwan Kim; Ronald Schonwetter; Benjamin Djulbegovic
Journal:  PLoS One       Date:  2012-10-17       Impact factor: 3.240

8.  Protocol for a systematic review of the diagnostic and prognostic utility of tests currently available for the detection of aspirin resistance in patients with established cardiovascular or cerebrovascular disease.

Authors:  Smriti Raichand; David Moore; Richard D Riley; Marie Lordkipanidzé; Janine Dretzke; Jennifer O'Donnell; Sue Jowett; Sue Bayliss; David A Fitzmaurice
Journal:  Syst Rev       Date:  2013-02-26

Review 9.  Prognosis Research Strategy (PROGRESS) 3: prognostic model research.

Authors:  Ewout W Steyerberg; Karel G M Moons; Danielle A van der Windt; Jill A Hayden; Pablo Perel; Sara Schroter; Richard D Riley; Harry Hemingway; Douglas G Altman
Journal:  PLoS Med       Date:  2013-02-05       Impact factor: 11.069

10.  External validation of a Cox prognostic model: principles and methods.

Authors:  Patrick Royston; Douglas G Altman
Journal:  BMC Med Res Methodol       Date:  2013-03-06       Impact factor: 4.615
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.